Impact BioMedical Inc. (IBO) AMEX
0.52
-0.0333(-6.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.93M |
| Enterprise Value | 15.93M |
| P/E Ratio | -4.37 |
| PEG Ratio | 0.16 |
| Price/Sales Ratio | 166.96 |
| Price/Book Ratio | 4.9 |
| Enterprise/Revenue | 166.44 |
| Enterprise/EBITDA | -0.47 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -329.69 |
| Operating Margin | -117.82 |
Management Effectiveness
| Return On Assets | -0.75 |
| Return On Equity | -26.75 |
Income Statement
| Revenue | 32,000 |
| Revenue/Share | 0 |
| Gross Profit | -392,000 |
| EBITDA | -12.51M |
| Net Income | -11.84M |
| Diluted EPS | -0.38 |
Balance Sheet
| Total Cash | 20,000 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.22 |
| Book Value Per Share | 0.14 |
Price History
| 52-Week Change | 2.54 |
| 52-Week High | 1.95 |
| 52-Week Low | 0.36 |
| Moving Average 50 Days | 0.61 |
| Moving Average 200 Days | 0.55 |
Statistics
| Average Volume | 4.3M |
| Shares Outstanding | 12.5M |
| % Held by Institutions | 11.8 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
